Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gowen

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosisM W Lark, G B Stroup, S M Hwang, et al.
BMC Systems Biology|June 27, 2015
Genome-scale resources for Thermoanaerobacterium saccharolyticumDevin H Currie, Babu Raman, Christopher M Gowen, et al.
Journal of Global Oncology|November 3, 2017
Project ECHO: A Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource SettingsMelissa S Lopez, Ellen S Baker, Andrea M Milbourne, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis modelW H Miller, W E Bondinell, R D Cousins, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.
Journal of Medicinal Chemistry|January 14, 2000
Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimeticW H Miller, D P Alberts, P K Bhatnagar, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosisM W Lark, G B Stroup, S M Hwang, et al.
BMC Systems Biology|June 27, 2015
Genome-scale resources for Thermoanaerobacterium saccharolyticumDevin H Currie, Babu Raman, Christopher M Gowen, et al.
Journal of Global Oncology|November 3, 2017
Project ECHO: A Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource SettingsMelissa S Lopez, Ellen S Baker, Andrea M Milbourne, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis modelW H Miller, W E Bondinell, R D Cousins, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.
Journal of Medicinal Chemistry|January 14, 2000
Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimeticW H Miller, D P Alberts, P K Bhatnagar, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 12